Paulo Monteiro Araujo

Ms. Paulo Monteiro Araujo


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
DGDuanne Mendes Gomes
Duanne Mendes Gomes
LMLyghia Maria Araújo Meirelles
Lyghia Maria Araújo Meirelles
PAPaulo Monteiro Araujo
Paulo Monteiro Araujo
RSRayran Walter Ramos de Sousa
Rayran Walter Ramos de Sousa
PFPaulo Michel Pinheiro Ferreira
Paulo Michel Pinheiro Ferreira
FRFernanda Nervo Raffin
Fernanda Nervo Raffin
(1) Background: Riparin-A presents several pharmacological activities already elucidated, such as antimicrobial modulator, antileishmania, anxiolytic, anti-inflammatory, antinociceptive, and antioxidant. Even with important bioactive effects, the applicability of Riparin-A is limited due to its low solubility in water, impairing its dissolution in biological fluids. Thus, the objective of this study was to develop a nanohybrid based on Riparin-A and Laponite to obtain a better dissolution profile and evaluate its cytotoxic potential. (2) Methods: The formation of a hybrid system was highlighted by X-ray powder diffraction, infrared spectroscopy, and thermal analysis. Solubility, dissolution, and cytotoxicity studies were performed; (3) Results: An increase in the solubility and aqueous dissolution rate of Riparin-A was observed in the presence of clay. Diffractometric analysis of the hybrid system suggests the amorphization of Riparin-A, and thermal analyses indicated attenuation of decomposition and melting of the Riparin-A after interaction with clay. Furthermore, the nanosystem did not exhibit cytotoxic activity on normal and tumorigenic lines. (4) Conclusions: These results are promising for the development of the Riparin-A/Laponite nanosystem for therapeutic purposes, suggesting an increase in the range of possible routes of administration and bioavailability of this bioactive compound.